Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Vall díHebron University Hospital, Barcelona, Spain



Survival: 17.1 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: Spain
   
City/State/Province: Barcelona
   
Hospital: Vall díHebron University Hospital
   
Journal: Link
   
Date: 3/2013

Description:
Patients:
This phase 2 study involved 295 refractory/recurrent ovarian cancer patients with a median age of 58 years.

Treatment:
Patients were treated with the chemotherapy agent called trabectedin.

Toxicities:
There were two treatment-related deaths due to multi organ failure and heart attack. Grade 4 neutropenia and liver toxicity, and grade 3 fatigue, nausea, and vomiting were also reported.

Results:
The median overall survival was 17.1 months.

Support:
This study was supported by PharmaMar, makers of Yondelis (brand name for trabectedin).

Correspondence: Dr. Jose Maria del Campo; email: jmcampo@vhio.net

E-mail to a Friend Email Physician More Information